TORONTO, Dec. 22, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I), today announced that it has notified the U.S. Food and Drug Administration (FDA) that it has ...

NEW YORK (Reuters) - Wyeth said on Tuesday it had launched a U.S. generic form of its blockbuster Protonix heartburn drug, even as it continues legal action to stop other companies from selling their ...

August 10, 2007 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for dantrolene sodium injectable 20 mg/vial for the management of malignant hyperthermia; ...

PITTSBURGH — The Food and Drug Administration has approved a treatment for gastroesphageal reflux disease made by a subsidiary of Mylan, the generic drug maker said Monday. The FDA approved Matrix ...

TORONTO, Oct. 18, 2010 (GLOBE NEWSWIRE) -- Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) today announced that the Food and Drug Administration (FDA) has accepted for filing its ...

TEL AVIV, Dec 24 (Reuters) - Israel's Teva Pharmaceutical Industries Ltd on Monday raised its 2007 earnings outlook due to the launch of its generic version of Wyeth's ulcer drug Protonix. The product ...

NEW YORK Wyeth on Tuesday announced the U.S. launch of its own generic version of Protonix (pantoprazole) in response to December’s at-risk launch of a generic version by Teva Pharmaceuticals.

One batch of a common heartburn drug was recalled over discolored tablets, according to the FDA. Only certain bottles are affected, so check your batch number and look for unusual tablet color or ...

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that ...

April 15, 2004 — The U.S. Food and Drug Administration (FDA) has approved an intravenous formulation of pantoprazole sodium, a cardioverter defibrillator system, and a first-time generic for ribavirin ...

NEW YORK — Two generic drugmakers will pay $2.15 billion to Pfizer and Takeda Pharmaceutical to settle a patent fight over the heartburn treatment Protonix. Teva Pharmaceutical Industries Ltd., one of ...

Jerusalem, April 23, 2010 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that a jury returned a verdict in the U.S. District Court for the District of New Jersey finding that ...